trialsmeinertsway.com::Guidelines, Rules, Suggestions & Reminders

Guidelines, Rules, Suggestions & Reminders

Title	Date

Specimen banking	17 Dec 10
On posting study protocols and consent forms to study websites	12 Jul 11
Guidelines on maintaining study protocols in trials	05 Aug 11
On the morphing of trials to followup studies	25 Aug 11
On whether coordinating centers should have names of persons studied	30 Aug 11
Page numbering, footers, and tables of contents	06 Sep 11
E-mail and trials	25 Oct 11
Keeping track of study data in multicenter trials	31 Oct 11
In search of the Yellow Brick Road for coordinating centers	18 Nov 11
Coordinating center takeovers	30 Nov 11
My Yellow Brick Road for blackouts, shielding, firewalls, and access to study results in multicenter trials	06 Dec 11
When is fraud fraud?	13 Dec 11
The story of the duplicate LSOCA patient	25 Jun 12
Multiple enrollments in trials	28 Jun 12
When to terminate IRB approvals in trials?	09 Oct 12
On the magic of transforming human subject research data to non human subject research data	15 Oct 12
Multicenter trials: Consents and coordinating centers	10 Dec 12
My rules as a trialist	08 May 13
On masked data monitoring committees	15 Jan 14
Toward a better system of registration?	06 Feb 15
Dating	24 Oct 16
Page numbering	11 Nov 16
On the difference between design variables and outcomes in trials	20 Feb 18
On investigator meetings and site visiting in trials	21 Jun 18
Things we should know about trials	02 Nov 18
Robert’s Rules of Order and clinical trials	06 Feb 19
A DSMB manifesto	13 Feb 19
On reasons why DSMBs should not be masked	26 Feb 19
Data and safety monitoring boards: The downside	14 Mar 19
Counting 101	25 Jun 19
Counting 102	10 Jul 19
Slide rules	15 Oct 19
Archiving	11 Feb 20
You cannot study those who do not consent!	17 Dec 20
Patient, subject, or participant in trials?	19 Jul 22

Last Updated: 21 Jul 2022

(Click here to get Adobe Acrobat Reader for free)